Beijing, February 13, 2007 – LAWFUEL – China Law & Business – Orr…

Beijing, February 13, 2007 – LAWFUEL – China Law & Business – Orrick, Herrington & Sutcliffe LLP announced today that Dr. Xiang Wang, formerly co-head of Jones Day’s Mainland China IP practice, has joined the firm as a partner in its Beijing office. Honored as one of the “30 Hottest Lawyers” by a leading Asian legal publication, Dr. Wang complements Orrick’s already strong IP practice in the U.S. and Asia and will further bolster the firm’s practice in China. Dr. Wang will also lead Orrick’s China Intellectual Property practice.

“The reasons for the continued growth of our Intellectual Property practice in China are clear,” said Gary Weiss, chair of Orrick’s intellectual property practice. “Companies with substantial operations in China are increasingly the focus of IP disputes throughout the world. We view the China IP practice not only as a very significant end in itself, but also a means to strengthen our position and attractiveness to corporate and M&A clients in technology-intensive industries that make up a growing portion of the Chinese economy.”

Dr. Wang specializes in representing Chinese and multinational companies with substantial operations in China, in multi-jurisdictional intellectual property litigation in the United States, Hong Kong, elsewhere in Asia and in Europe, and before the International Trade Commission. He also counsels his multinational clients in all aspects of their intellectual property rights in China and throughout the world.

Additionally, Dr. Wang coordinates prosecution, enforcement, and technology transfer-licensing for substantial patent and trademark portfolios for companies doing business in China, and he regularly handles office actions, oppositions, patent invalidation proceedings, anti-counterfeiting and anti-piracy efforts, and patent and trademark enforcement litigation. Dr. Wang has extensive experience handling IP work relating to many technologies, and he has represented medical device and pharmaceutical companies in regulatory compliance and proceedings in China.

“Orrick’s strong Intellectual Property practice combined with its robust international platform offers the firm’s clients unique cross-border IP capabilities,” said Dr. Wang. “I look forward to contributing to the growth of the firm’s China Focus and working with my colleagues in the IP practices across Asia, Europe and the United States.”

Dr. Wang was honored by Asian Legal Business as one of the “30 Hottest Lawyers” in 2005 for his work in handling cross-border patent and trademark litigation and prosecution. He currently serves as vice chair of the Intellectual Property Committee of the American Chamber of Commerce in Shanghai and as counsel for the R&D-based Pharmaceutical Association in China. In addition, he serves as an adjunct professor of electrical and biomedical engineering at Drexel University in Philadelphia, Pennsylvania.

As an inventor himself, Dr. Wang has been awarded four United States medical-technology patents. Before entering law school, Dr. Wang held a number of key technical positions at a variety of institutions, including serving as Executive Director of R&D at Renaissance Technology and Director of Medical Research for the Department of Surgery at Episcopal Hospital in Philadelphia.

Dr. Wang received a PhD in electrical and computer engineering from Drexel University in 1991. He received a B.S. fro Sichuan University in 1982 and a M.S. from Drexel in 1987. He also obtained law degrees in both China and the U.S. He received a Chinese Certificate of Law from China University of Political Science and Law in 1996, and a J.D. from the University of Maryland in 1998.

###

About Orrick

Orrick, Herrington & Sutcliffe LLP is an international law firm with more than 980 lawyers in North America, Europe and Asia. The firm focuses on litigation, complex and novel finance and innovative corporate transactions. Orrick clients include Fortune 100 companies, major industrial and financial corporations, commercial and investment banks, high-growth companies, governmental entities, start-ups and individuals. The firm’s 18 offices are located in Beijing, Hong Kong, London, Los Angeles, Milan, Moscow, New York, Orange County, Pacific Northwest, Paris, Rome, Sacramento, San Francisco, Shanghai, Silicon Valley, Taipei, Tokyo and Washington, D.C.

Scroll to Top